Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a workshop at the 2001 tandem meetings

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 9, 2001, Pages 473-485

  Antin, Joseph H ^a   Childs, Richard ^a   Filipovich, Alexandra H ^a   Giralt, Sergio ^a   Mackinnon, Stephen ^a   Spitzer, Thomas ^a   Weisdorf, Daniel ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Allogeneic transplantation; Lymphohematopoietic chimerism; Restriction fragment length polymorphism

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MELPHALAN; MONOCLONAL ANTIBODY; THYMOCYTE ANTIBODY;

BLOOD ANALYSIS; BLOOD CELL; BONE MARROW CELL; BONE MARROW DEPRESSION; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DONOR; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HUMAN; IMMUNE DEFICIENCY; LABORATORY; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MEASUREMENT; MEDICAL RESEARCH; MYELOID LEUKEMIA; PRACTICE GUIDELINE; PREDICTION; REGISTER; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; VARIABLE NUMBER OF TANDEM REPEAT; WORKSHOP;

EID: 0034769445     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2001.v7.pm11669214     Document Type: Article

References (39)

1. Microchimerism and rejection: A meta-analysis
2. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma
3. Microchimerism of maternal origin persists into adult life
4. Successful allogenic bone marrow transplantation in man: Chimerism, induced specific tolerance and possible anti-leukemic effects
5. The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants
6. Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: A stable equilibrium
7. Cytogenetic follow-up studies of recipients of T-cell depleted allogeneic bone marrow
8. Gene markers in human bone marrow transplantation
9. Immunoglobulin production of donor origin after marrow transplantation for acute leukemia or aplastic anemia
10. A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes
11. Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphisms
12. Hypervariable "minisatellite" regions in human DNA
13. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
14. Amplification of human minisatellites by the polymerase chain reaction: Towards DNA fingerprinting of single cells
15. Quantitative evaluation of post-bone marrow transplant engraftment status using fluorescent-labeled variable number of tandem repeats
16. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection
17. Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT
18. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers
19. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers
20. Sequence analysis and characterization of stutter products at the tetranucleotide repeat locus vWA
21. Lymphoid chimerism after allogeneic bone marrow transplantation. Y- chromatin staining of peripheral T and B lymphocytes and allotyping of serum immunoglobulins
22. Mixed blood chimerism in T cell depleted bone marrow transplant recipients: Evaluation using DNA polymorphism
23. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
24. Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation
25. Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia
26. Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation
27. Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies
28. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen
29. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation
30. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
31. Strategy to detect chimerism in allogeneic bone marrow transplant recipients by PCR-amplification fragment length polymorphism analysis of microsatellite polymorphisms
32. Analysis of late graft failure after allogeneic bone marrow transplantation: Detection of residual host cells using amplification of variable number of tandem repeats loci
33. Flow Cytometry
34. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
35. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
36. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease
37. Study of chimerism in long-term survivors after bone marrow transplantation for severe acquired aplastic anemia
38. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
39. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses